Get the Stockscreener App
0.7792
2.10%
-0.0167
Dyadic International Inc De stock is traded at $0.7792, with a volume of 130.72K.
It is down -2.10% in the last 24 hours and up +7.92% over the past month.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$0.7959
Open:
$0.8
24h Volume:
130.72K
Relative Volume:
0.55
Market Cap:
$28.39M
Revenue:
$3.81M
Net Income/Loss:
$-7.29M
P/E Ratio:
-3.6428
EPS:
-0.2139
Net Cash Flow:
$-5.72M
1W Performance:
+15.37%
1M Performance:
+7.92%
6M Performance:
-14.30%
1Y Performance:
-16.22%
1-Day Range:
$0.75
$0.81
1-Week Range:
$0.6568
$0.81
52-Week Range:
$0.6546
$1.346
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.45 | 3.33B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.19 | 397.06M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.19 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.83 | 254.39M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
47.19 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Resumed | H.C. Wainwright | Buy |
| Sep-08-25 | Initiated | Craig Hallum | Buy |
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Dyadic Showcases C1 Platform Amid Ebola Preparedness Surge - TipRanks
De-Inking Enzymes Market is Booming Worldwide | Major Giants Megazyme, BASF SE, DuPont - openPR.com
Enzyme Stabilizer Market Trends Support A 6.7% CAGR Outlook Through The Forecast Period - openPR.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
Dyadic Under $1 as Investors Eye June Vote - Bez Kabli
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC) - The Globe and Mail
Dyadic International Launches Recombinant Human Albumin and Bovine Chymosin - asatunews.co.id
Analysts Offer Insights on Industrial Goods Companies: DroneShield Limited (OtherDRSHF), CryoPort (CYRX) and Deere (DE) - The Globe and Mail
Dyadic International (DYAI) Surges 13.8% – Key Levels in FocusETF AUM Growth - newsline.com
Dyadic and Scripps Research Partner to Accelerate Hantavirus Antibody and Vaccine Development Using C1 Biologic Platform - Minichart
Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ET - GlobeNewswire Inc.
Skyline Corporate Communications Group, LLC Announces - GlobeNewswire
Dyadic International’s Earnings Call Shows Early Momentum - The Globe and Mail
Dyadic International Earnings Call Highlights Early Momentum - TipRanks
Earnings call transcript: Dyadic’s Q1 2026 revenue surges 182% despite EPS miss By Investing.com - Investing.com Australia
Japan’s First LNG Shipment via Hormuz Since Strait’s De Facto Closure Marks Energy Security MilestoneAnalyst Coverage Count - The Legal Advocate
Dyadic International stock (US26746E1055): Shares climb after recent momentum - AD HOC NEWS
Dyadic International, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips - Investing.com India
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips By Investing.com - Investing.com India
Transcript: Dyadic International Q1 2026 Earnings Conference Call - Benzinga
Dyadic International (NASDAQ: DYAI) grows Q1 2026 revenue but flags going-concern risks - Stock Titan
Specialty Enzymes Market Overview, Emerging Trends, and Key Player Analysis - openPR.com
Analysis of Segments and Major Growth Areas in the Protein Hydrolysis Enzymes Market - openPR.com
Unusual VolumeStock ScreenerNews - Finviz
Biogen Inc. (BIIB)Dual Wall Street Upgrades Signal Bullish Pipeline Catalyst UpsideAnalyst Coverage Count - newsline.com
Dyadic International stock (US26746E1055): Is its biotech platform strong enough to unlock new upsid - AD HOC NEWS
Dyadic International Stock: Biotechnology Innovator Focused on C1 Platform Amid Earnings Challenges - AD HOC NEWS
Dyadic International Earnings Call Highlights Commercial Pivot - TipRanks
Dyadic International, Inc.'s (NASDAQ:DYAI) Path To Profitability - simplywall.st
Dyadic International Q4 2025 Earnings Call Transcript - MarketBeat
Dyadic Applied BioSolutions Reports 2025 Financial Results, Commercial Launches, and Strategic Partnerships in Animal-Free Protein Production 12346 - Minichart
Dyadic Applied BioSolutions: Innovative Microbial Protein Production Platforms for Life Sciences, Food, and Industrial Markets - Minichart
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Highlights: Navigating Transition with ... By GuruFocus - ca.investing.com
Dyadic International’s ability to sustain operations for the next year and avoid significant dilution depends on the effectiveness of its shift toward commercial strategies - Bitget
Dyadic (DYAI) Q4 2025 Earnings Call Transcript - theglobeandmail.com
Earnings call transcript: Dyadic Q4 2025 reveals revenue decline, stock up 3.32% - Investing.com Australia
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress - Yahoo Finance Singapore
Dyadic (NASDAQ: DYAI) posts lower 2025 revenue and wider annual net loss - Stock Titan
Dyadic International, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - AOL.com
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices - GlobeNewswire
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 - The Manila Times
Dyadic to detail full-year 2025 results in March 25 investor call - Stock Titan
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - GlobeNewswire
Decliners Report: Can Dyadic International Inc outperform under higher oil pricesWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Dyadic International Establishes At-the-Market Equity Offering Program - The Globe and Mail
Dyadic and Fermbox Bio Launch First Product Under Expanded - GlobeNewswire
Dyadic Applied BioSolutions and Inzymes ApS Announce - GlobeNewswire
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone - Yahoo Finance
Dyadic's Strategic Pivot: From Platform to Product - AD HOC NEWS
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):